HMR-1426 is gastric emptying inhibitor potentially for the treatment of obesity. In one study, HMR1426 showed an anorectic potential in rats and decreased body weight and fat mass. This was achieved solely by reducing food intake without influencing overall energy expenditure or behavior suggesting a peripheral mode of action. Thus, HMR1426 can be considered a potential new drug for obesity treatment. References: Ortmann S, Kampe J, Gossel M, Bickel M, Geisen K, Jahne G, Lang HJ, Klaus S. The novel antiobesic HMR1426 reduces food intake without affecting energy expenditure in rats. Obes Res. 2004 Aug;12(8):1290-7. PubMed PMID: 15340112.

纯度：≥98%

CAS：262376-75-0